2016
DOI: 10.3390/ijms17050796
|View full text |Cite
|
Sign up to set email alerts
|

Prodrug Strategies for Paclitaxel

Abstract: Paclitaxel is an anti-tumor agent with remarkable anti-tumor activity and wide clinical uses. However, it is also faced with various challenges especially for its poor water solubility and low selectivity for the target. To overcome these disadvantages of paclitaxel, approaches using small molecule modifications and macromolecule modifications have been developed by many research groups from all over the world. In this review, we discuss the different strategies especially prodrug strategies that are currently… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
64
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 77 publications
(67 citation statements)
references
References 140 publications
0
64
0
Order By: Relevance
“…On the other hand, the OH group at C-2 is binding site between paclitaxel and microtubules. Although C-7 to C-10 do not interacted directly, but affects the affinity of Pglycoprotein [11].…”
Section: Mechanism Of Paclitaxel Kill Cancermentioning
confidence: 95%
See 2 more Smart Citations
“…On the other hand, the OH group at C-2 is binding site between paclitaxel and microtubules. Although C-7 to C-10 do not interacted directly, but affects the affinity of Pglycoprotein [11].…”
Section: Mechanism Of Paclitaxel Kill Cancermentioning
confidence: 95%
“…CELLS Paclitaxel has a rigid center ring and flexible side chains [11]. Paclitaxel put to death cancer cells by inhibiting chromosomes separation on metaphase [12].…”
Section: Mechanism Of Paclitaxel Kill Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, many new drug delivery platforms for PTX, including prodrugs, 11 liposomes, 12 solid lipid nanoparticles 13 and polymeric micelles, 14 have emerged to circumvent the drawbacks of PTX. Polymeric micelles have been regarded as an effective nanoplatform because of their ability to encapsulate hydrophobic agents into their "coreshell" structure and deliver these agents to tumor regions by the enhanced permeability and retention (EPR) effect.…”
Section: Introductionmentioning
confidence: 99%
“…2 However, their use is limited by toxicity, including hypersensitivity reactions and peripheral neuropathy, 3 their extremely poor water solubility (0.3 µg/mL) that requires the use of toxic solvents, eg, Cremophor EL/ethanol ® , and the need of relatively high doses to provide therapeutic effects. 3,4 Advanced drug delivery systems (DDSs), such as nanoparticles (NPs), may help overcoming pharmacokinetic and pharmacodynamic limitations of anticancer drugs. 4 Different preparation procedures have been proposed for keratin NPs (KER-NPs) synthesis.…”
Section: Introductionmentioning
confidence: 99%